Kentucky Retirement Systems Nektar Therapeutics Transaction History

Kentucky Retirement Systems

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 05, 2019	SELL	$16.91 - $36.27 $137,258 - $294,403	-8,117 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$31.0 - $36.3 $15,655 - $18,331	505 Added 6.63%	8,117 $289,000
Q1 2019 May 22, 2019	BUY	$31.58 - $46.35 $2,621 - $3,847	83 Added 1.1%	7,612 $256,000
Q4 2018 Feb 25, 2019	BUY	$30.43 - $56.65 $5,599 - $10,423	184 Added 2.51%	7,529 $247,000
Q3 2018 Nov 19, 2018	BUY	$46.46 - $68.49 $341,248 - $503,059	7,345 New	7,345 $0

Q3 2018 Nov 16, 2018	SELL	$46.46 - $68.49 $317,832 - $468,540	-6,841 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$46.25 - $104.45 $72,011 - $162,628	-1,557 Reduced 18.54%	6,841 $334,000
Q1 2018 May 07, 2018	BUY	$57.4 - $108.44 $482,045 - $910,679	8,398 New	8,398 $892,000

126

109M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $259M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Kentucky Retirement Systems, based on Form 13F filings with the SEC.

Stay updated on Kentucky Retirement Systems with notifications on news.